Baseline characteristics of participants in the randomized national lung screening trial

Journal of the National Cancer Institute

Volumn 102, Issue 23, 2010, Pages 1771-1779

  Aberle, Denise R ^a   Adams, Amanda M ^b   Berg, Christine D ^c   Clapp, Jonathan D ^d   Clingan, Kathy L ^e   Gareen, Ilana F ^b   Lynch, David A ^f   Marcus, Pamela M ^c   Pinsky, Paul F ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BROWN UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

^e WESTAT   (United States)

^f DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGED; ARTICLE; CANCER CENTER; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HEALTH CARE SURVEY; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL LUNG SCREENING TRIAL; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOM SAMPLE; RANDOMIZED CONTROLLED TRIAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THORAX RADIOGRAPHY;

AGE DISTRIBUTION; AGED; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS CHEST X-RAY; MASS SCREENING; MIDDLE AGED; MINORITY GROUPS; OCCUPATIONAL EXPOSURE; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; SMOKING; TOMOGRAPHY, SPIRAL COMPUTED; UNITED STATES;

EID: 78649831354     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq434     Document Type: Article

References (20)

1. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2007.
2. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Program (ELCAP): overall design and fndings from baseline screening. Lancet. 1999;354:99-105.
3. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355(17):1763-1771.
4. Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002;20(4): 911-920.
5. Sone S, Li F, Yang ZG, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer. 2001;84(1):25-32.
6. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: fve-year prospective experience. Radiology. 2005;235(1):259-265.
7. Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest. 2002;122(1):15-20.
8. Diederich S, Thomas M, Semik M, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol. 2004;14(4): 691-702.
9. Blanchon T, Brechot JM, Grenier PA, et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer. 2007;58(1):50-58.
10. The National Lung Screening Trial. Overview and study design: The National Lung Screening Trial Research Team. Radiology. 2010. doi:10.1148/radiol.10091808.
11. US Department of Commerce, Census Bureau (2006). National Cancer Institute and Centers for Disease Control and Prevention Co-sponsored Tobacco Use Special Cessation Supplement to the Current Population Survey (2003). http://riskfactor.cancer.gov/studies/tus-cps/info.html Accessed October 18, 2010.
12. Pinsky PF, Miller A, Kramer BS, et al. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol. 2007;165(8):874-881.
13. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ. 1992;147(10):1477-1488. (Pubitemid 23008477)
14. Gottschall EB. Occupational and environmental thoracic malignancies. J Thorac Imaging. 2002;17(3):189-197.
15. Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines. (2nd edition). Chest. 2007;132 (3 suppl):29S-55S.
16. Mastrangelo G, Ballarin MN, Bellini E, et al. Feasibility of a screening programme for lung cancer in former asbestos workers. Occup Med (Lond). 2008;58(3):175-180.
17. Tiitola M, Kivisaari L, Huuskonen MS, et al. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer. 2002;35(1):17-22.
18. Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93(7):825-833.
19. De Torres JP, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007;132(6):1932-1938.
20. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176(3):285-290.